Kopran Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kopran Limited with three other
companies in this sector in India:
RPG Life Sciences Limited
sales of 3.04 billion Indian Rupees [US$47.27 million]
Albert David Limited
(3.16 billion Indian Rupees [US$49.11 million]
Advanced Enzyme Technologies Ltd
(3.31 billion Indian Rupees [US$51.46 million]
During the year ended March of 2017, sales at
Kopran Limited were 3.10 billion Indian Rupees (US$48.10 million).
increase of 4.5%
versus 2016, when the company's sales were 2.96 billion Indian Rupees.
Despite this increase, sales are still
below the level achieved in 2015, when Kopran Limited
reported sales of 3.26 billion Indian Rupees.